Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Protagonist Therapeutics (PTGX) Receivables - Net (2017 - 2021)

Protagonist Therapeutics' Receivables - Net history spans 5 years, with the latest figure at $100000.0 for Q1 2021.

  • For Q1 2021, Receivables - Net fell 66.67% year-over-year to $100000.0; the TTM value through Mar 2021 reached $100000.0, down 66.67%, while the annual FY2019 figure was $300000.0, 2.91% down from the prior year.
  • Receivables - Net for Q1 2021 was $100000.0 at Protagonist Therapeutics, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $700000.0 in Q3 2019 and bottomed at $19000.0 in Q2 2017.
  • The 5-year median for Receivables - Net is $103000.0 (2017), against an average of $199266.7.
  • The largest annual shift saw Receivables - Net skyrocketed 459.38% in 2019 before it tumbled 72.07% in 2020.
  • A 5-year view of Receivables - Net shows it stood at $58000.0 in 2017, then surged by 432.76% to $309000.0 in 2018, then dropped by 2.91% to $300000.0 in 2019, then crashed by 66.67% to $100000.0 in 2020, then changed by 0.0% to $100000.0 in 2021.
  • Per Business Quant, the three most recent readings for PTGX's Receivables - Net are $100000.0 (Q1 2021), $100000.0 (Q2 2020), and $300000.0 (Q1 2020).